ID: ALA4554149

Max Phase: Preclinical

Molecular Formula: C11H11Cl2N

Molecular Weight: 228.12

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C#CCN(C)Cc1c(Cl)cccc1Cl

Standard InChI:  InChI=1S/C11H11Cl2N/c1-3-7-14(2)8-9-10(12)5-4-6-11(9)13/h1,4-6H,7-8H2,2H3

Standard InChI Key:  BNTPRFUNFJNCJB-UHFFFAOYSA-N

Associated Targets(Human)

Pyrroline-5-carboxylate reductase 1, mitochondrial 71 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 228.12Molecular Weight (Monoisotopic): 227.0269AlogP: 3.06#Rotatable Bonds: 3
Polar Surface Area: 3.24Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.78CX LogP: 3.35CX LogD: 3.34
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.72Np Likeness Score: -1.54

References

1. Milne K, Sun J, Zaal EA, Mowat J, Celie PHN, Fish A, Berkers CR, Forlani G, Loayza-Puch F, Jamieson C, Agami R..  (2019)  A fragment-like approach to PYCR1 inhibition.,  29  (18): [PMID:31362921] [10.1016/j.bmcl.2019.07.047]

Source